Skip to main content

Table 1 Patient information

From: Risk of secondary cancers from scattered radiation during intensity-modulated radiotherapies for hepatocellular carcinoma

ID

Sex

Age

Disease

Stage

PTV volume (cc)

Prescription dose (Gy)

1

Male

62

HCC

III

483

55.0

2

Male

54

HCC

I

60

66.0

3

Male

59

HCC

III

421

52.5

4

Female

49

HCC

IV

2112

60.0

5

Female

42

HCC

IV

214

72.0